期刊
CANCER LETTERS
卷 232, 期 2, 页码 139-147出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2005.02.002
关键词
platelet-derived growth factor; central nervous systern; gliomas
类别
资金
- NCI NIH HHS [R01 CA09489, UO1CA894314-1] Funding Source: Medline
- NIGMS NIH HHS [GM07739] Funding Source: Medline
Platelet-derived growth factor (PDGF) has long been implicated in cancer and is known to be involved in many biological processes. In Central Nervous System (CNS) neoplasms, particularly gliomas, PDGF is often over-expressed. However, what role PDGF plays in tumor progression remains to be fully described. A wide range of work from in vitro studies to mouse models have implicated the PDGF pathway in various processes including proliferation, cellular migration, development, and angiogenesis. Being a secreted factor, PDGF not only has autocrine effects on producing cells but also has potential for paracrine effects on other tumor cells and the tumor microenvironment. The development of small molecules that inhibit the PDGF receptor and various subsequent signaling components promises, to introduce new approaches to the treatment of gliomas. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据